Literature DB >> 22374148

Defining the coronary slow flow phenomenon.

John F Beltrame.   

Abstract

Mesh:

Year:  2012        PMID: 22374148     DOI: 10.1253/circj.cj-12-0205

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


× No keyword cloud information.
  17 in total

1.  Are biventricular systolic functions impaired in patient with coronoray slow flow? A prospective study with three dimensional speckle tracking.

Authors:  Tuğba Kemaloğlu Öz; Mehmet Eren; Işıl Atasoy; Tayfun Gürol; Özer Soylu; Bahadır Dağdeviren
Journal:  Int J Cardiovasc Imaging       Date:  2017-01-06       Impact factor: 2.357

2.  Vessel heterogeneity of TIMI frame count and its relation to P-wave dispersion in patients with coronary slow flow.

Authors:  Xiaodong Zhuang; You Peng; Adham Sameer A Bardeesi; Ekhlas Samir A Bardisi; Xinxue Liao; Chufan Luo
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

3.  Left Ventricular Diastolic Function: Comparison of Slow Coronary Flow Phenomenon and Left Ventricular Hypertrophy in the Absence of Obstructive Coronary Disease.

Authors:  Niya E Semerdzhieva; Stefan V Denchev; Mariana V Gospodinova
Journal:  Cureus       Date:  2022-05-06

Review 4.  Cardiac Syndrome X: update 2014.

Authors:  Shilpa Agrawal; Puja K Mehta; C Noel Bairey Merz
Journal:  Cardiol Clin       Date:  2014-06-02       Impact factor: 2.213

5.  Early Thrombosuction and Tirofiban Use in Knee and Below-Knee Arterial Thrombosis.

Authors:  Ulas Bildirici; Umut Celikyurt; Sadan Yavuz; Emir Dervis; Qurban Adina; Dilek Ural
Journal:  Med Sci Monit       Date:  2017-04-30

6.  Association between increased serum alkaline phosphatase and the coronary slow flow phenomenon.

Authors:  Yong Wang; Mou-Jie Liu; Hui-Min Yang; Chun-Yan Ma; Peng-Yu Jia; Da-Lin Jia; Ai-Jie Hou
Journal:  BMC Cardiovasc Disord       Date:  2018-07-04       Impact factor: 2.298

7.  Relationship Between the Reciprocal Change in Inflammation-Related Biomarkers (Fibrinogen-to-Albumin and hsCRP-to-Albumin Ratios) and the Presence and Severity of Coronary Slow Flow.

Authors:  Osman Kayapinar; Cem Ozde; Adnan Kaya
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

8.  Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow.

Authors:  Hongmei Niu; Zhenzhen Wei; Yanling Zhang; Jian He; Danyan Jia
Journal:  Exp Ther Med       Date:  2017-11-10       Impact factor: 2.447

9.  Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow.

Authors:  Yuan-Ting Zhu; Ling-Ping Zhu; Zhen-Yu Wang; Xue-Ting Qiu; Wan-Zhou Wu; Wei-Wang Liu; Yu-Yu Feng; Wen-Kai Xiao; Xin Luo; Zhen-Yu Li; Chuan-Chang Li
Journal:  Cardiol Res Pract       Date:  2020-01-25       Impact factor: 1.866

10.  Atorvastatin improves the proliferation and migration of endothelial progenitor cells via the miR-221/VEGFA axis.

Authors:  Lihua Sun; Ying Zhang; Junshi Zhang; Juan Wang; Shifeng Xing
Journal:  Biosci Rep       Date:  2020-11-27       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.